Jenscare Scientific Co., Ltd.

Innovation Spirits

We have independently developed 10 minimally invasive interventional treatment solutions targeting tricuspid valve diseases, mitral valve diseases, aortic valve diseases, and heart failure. All products are based on our original innovation and possess global patents and independent intellectual property rights.

Scroll

Home > Products > Cardiogenic stroke protective intervention treatment products

SimuLock

Our independently developed SimuLock left atrial appendage occluder system is used for thrombus protection and stroke prevention, with an internationally leading technical path, achieving the first biomimetic principle anchoring and personalized customization.

About Us

Products

Business

R&D and Production

News Center

Investor Relations

Careers

Contact